Substance use among pregnant women is a significant public health issue. A range of adverse effects have been noted including increased risk of miscarriage and still birth, reduction in fetal growth, birth defects, developmental delay, growth retardation and neurological abnormalities.
Substance use amongst adolescents (those in the age group of 10-19) is an important public health issue in many countries of the region.
The Northern Territory prison population comprises 92% Indigenous Australians and 88% smokers. The NT prison-smoking ban creates a population-wide abstinence. We aim to extend this period of abstinence into the community.
This project will estimate the social and economic costs related to tobacco use in NSW for 2014. Mortality and morbidity costs attributable to smoking will be estimated as will lost productivity, costs due to fires and the intangible costs due to mortality attributable to smoking.
Tobacco smoking is a leading cause of preventable disease and death. Smoking rates are higher among disadvantaged Australians and facilitating smoking cessation in this group is a national health priority.
This study aimed to examine the feasibility of agonist maintenance treatment for the major psychoactive drug classes: opioids, nicotine, benzodiazepines, cannabis, psychostimulants and alcohol.
Compulsive hoarding is a debilitating disorder. Little is known of the substance use of hoarders, or the circumstances in which they die.
In this study, we will undertake detailed analyses of the largest cross-national epidemiologic study of mental and substance use disorders ever conducted. The WHO World Mental Health Survey (WMHS) initiative is a massive, unique endeavour.
Smoking cessation rates need to improve among low-socioeconomic status (low-SES) Australians if we are to reach a key national target as the health country: ≤ 9% smoking by 2020 . Recent (2013) National Drug Strategy Household Survey data show that persons from disadvantaged areas are three
Drug use can lead to significant financial, psychological, physical health and social consequences for family members. Despite this, previous economic assessments of drug use interventions have not included the costs and benefits to family members of treatment for the drug user.